Tao Gong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tao Gong has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Rongbin Zhou
Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
10 shared publications - Wei Jiang
Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
8 shared publications Yanqing Yang
Department of Clinical Laboratory, the First Affiliated Hospital of Bengbu Medical College, Bengbu 233004, China
5 shared publications- Andrea Cavalli
Institute for Research in Biomedicine, Università della Svizzera Italiana, Bellinzona, Switzerland
2 shared publications - Davide F. Robbiani
Institute for Research in Biomedicine, Università della Svizzera Italiana, 6500 Bellinzona, Switzerland
2 shared publications - Jacopo Sgrignani
Institute for Research in Biomedicine (IRB), Via Chiesa 5, 6500 Bellinzona, Switzerland
2 shared publications
Latest Publications
- 3 November 2026
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.
Purpose: Human endogenous retrovirus K (HERV-K/HML-2) is a human-specific endogenous retrovirus family that maintains intact open reading frames and is aberrantly expressed in multiple cancers. We tested whether HERV-K, specifically its envelope (Env) protein, marks clinically relevant diffuse large B-cell lymphoma (DLBCL) states and serves as a tractable immunotherapeutic target. Experimental Design: Locus-level transposable element (TE) and HERV expression was quantified in two independent DLBCL RNA-seq cohorts using curated TE annotation and a uniform alignment/counting workflow. Env transcript and protein expression (including cell-surface localization) was validated in lymphoma cell lines using RT-qPCR, immunoblotting, and flow cytometry. Functional relevance was assessed by siRNA-mediated Env knockdown. Candidate extracellular linear epitopes were predicted in silico and synthesized for serological and phage display assays. Anti-Env camelid VHHs were isolated, humanized, and tested for binding, antibody-dependent cellular cytotoxicity (ADCC), and antigen-dependent internalization. Results: TE transcripts stratified DLBCL into clinically distinct subgroups, and high HERV-K expression associated with an interferon/viral-mimicry program. Env RNA was detected in patient tumors and cell lines, and the protein was detected on the surface of a subset of lymphoma cell lines, in which Env knockdown reduced proliferation. A humanized heavy-chain antibody (FF-01) bound surface Env, induced selective ADCC in Env-positive models (reporter and primary NK-cell assays), and underwent rapid antigen-dependent internalization. Conclusions: HERV-K activity identifies biologically meaningful DLBCL states and exposes a targetable surface antigen. FF-01 provides proof of principle for antibody-based strategies against HERV-K Env, including ADCC- and ADC-oriented approaches.
- 3 November 2026
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
Aberrant expression of HERV-K envelope in lymphoma represents an opportunity for novel treatments.
Purpose: Human endogenous retrovirus K (HERV-K/HML-2) is a human-specific endogenous retrovirus family that maintains intact open reading frames and is aberrantly expressed in multiple cancers. We tested whether HERV-K, specifically its envelope (Env) protein, marks clinically relevant diffuse large B-cell lymphoma (DLBCL) states and serves as a tractable immunotherapeutic target. Experimental Design: Locus-level transposable element (TE) and HERV expression was quantified in two independent DLBCL RNA-seq cohorts using curated TE annotation and a uniform alignment/counting workflow. Env transcript and protein expression (including cell-surface localization) was validated in lymphoma cell lines using RT-qPCR, immunoblotting, and flow cytometry. Functional relevance was assessed by siRNA-mediated Env knockdown. Candidate extracellular linear epitopes were predicted in silico and synthesized for serological and phage display assays. Anti-Env camelid VHHs were isolated, humanized, and tested for binding, antibody-dependent cellular cytotoxicity (ADCC), and antigen-dependent internalization. Results: TE transcripts stratified DLBCL into clinically distinct subgroups, and high HERV-K expression associated with an interferon/viral-mimicry program. Env RNA was detected in patient tumors and cell lines, and the protein was detected on the surface of a subset of lymphoma cell lines, in which Env knockdown reduced proliferation. A humanized heavy-chain antibody (FF-01) bound surface Env, induced selective ADCC in Env-positive models (reporter and primary NK-cell assays), and underwent rapid antigen-dependent internalization. Conclusions: HERV-K activity identifies biologically meaningful DLBCL states and exposes a targetable surface antigen. FF-01 provides proof of principle for antibody-based strategies against HERV-K Env, including ADCC- and ADC-oriented approaches.
- Open Access
Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
Infection by SARS-CoV-2 leads to diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse COVID-19 outcomes. Instead, we discovered that antibodies against specific chemokines are omnipresent after COVID-19, associated with favorable disease, and predictive of lack of long COVID symptoms at one year post infection. Anti-chemokine antibodies are present also in HIV-1 infection and autoimmune disorders, but they target different chemokines than those in COVID-19. Monoclonal antibodies derived from COVID- 19 convalescents that bind to the chemokine N-loop impair cell migration. Given the role of chemokines in orchestrating immune cell trafficking, naturally arising anti-chemokine antibodies associated with favorable COVID-19 may be beneficial by modulating the inflammatory response and thus bear therapeutic potential. One-Sentence Summary: Naturally arising anti-chemokine antibodies associate with favorable COVID-19 and predict lack of long COVID.
Open AccessAnti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course
Infection by SARS-CoV-2 leads to diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse COVID-19 outcomes. Instead, we discovered that antibodies against specific chemokines are omnipresent after COVID-19, associated with favorable disease, and predictive of lack of long COVID symptoms at one year post infection. Anti-chemokine antibodies are present also in HIV-1 infection and autoimmune disorders, but they target different chemokines than those in COVID-19. Monoclonal antibodies derived from COVID- 19 convalescents that bind to the chemokine N-loop impair cell migration. Given the role of chemokines in orchestrating immune cell trafficking, naturally arising anti-chemokine antibodies associated with favorable COVID-19 may be beneficial by modulating the inflammatory response and thus bear therapeutic potential. One-Sentence Summary: Naturally arising anti-chemokine antibodies associate with favorable COVID-19 and predict lack of long COVID.
- 11 September 2020
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 18 (10) , 2422-2430
Synthetic vitamin K analogs inhibit inflammation by targeting the NLRP3 inflammasome
Vitamin K refers to a group of structurally similar vitamins that are essential for proper blood coagulation, as well as bone and cardiovascular health. Previous studies have indicated that vitamin K may also have anti-inflammatory properties, although the underlying mechanisms of its anti-inflammatory effects remain unclear. The NLRP3 inflammasome is a multiprotein complex, and its activation leads to IL-1β and IL-18 secretion and contributes to the pathogenesis of various human inflammatory diseases. Here, we show that synthetic vitamins K3 and K4 are selective, potent inhibitors of the NLRP3 inflammasome and specifically block the interaction between NLRP3 and ASC, thereby inhibiting NLRP3 inflammasome assembly. Moreover, we show that treatment with vitamin K3 or K4 attenuates the severity of inflammation in a mouse model of peritonitis. Our results demonstrate that vitamins K3 and K4 exert their anti-inflammatory effects by inhibiting NLRP3 inflammasome activation and indicate that vitamin K supplementation may be a treatment option for NLRP3-associated inflammatory diseases.
- 11 September 2020
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 18 (10) , 2422-2430
Synthetic vitamin K analogs inhibit inflammation by targeting the NLRP3 inflammasome
Vitamin K refers to a group of structurally similar vitamins that are essential for proper blood coagulation, as well as bone and cardiovascular health. Previous studies have indicated that vitamin K may also have anti-inflammatory properties, although the underlying mechanisms of its anti-inflammatory effects remain unclear. The NLRP3 inflammasome is a multiprotein complex, and its activation leads to IL-1β and IL-18 secretion and contributes to the pathogenesis of various human inflammatory diseases. Here, we show that synthetic vitamins K3 and K4 are selective, potent inhibitors of the NLRP3 inflammasome and specifically block the interaction between NLRP3 and ASC, thereby inhibiting NLRP3 inflammasome assembly. Moreover, we show that treatment with vitamin K3 or K4 attenuates the severity of inflammation in a mouse model of peritonitis. Our results demonstrate that vitamins K3 and K4 exert their anti-inflammatory effects by inhibiting NLRP3 inflammasome activation and indicate that vitamin K supplementation may be a treatment option for NLRP3-associated inflammatory diseases.
- 1 June 2020
- Published by Elsevier in Trends in Cell Biology
- Vol. 30 (6) , 467-477
Golgi Apparatus: An Emerging Platform for Innate Immunity
- 1 June 2020
- Published by Elsevier in Trends in Cell Biology
- Vol. 30 (6) , 467-477
Golgi Apparatus: An Emerging Platform for Innate Immunity
- 1 January 2020
- Published by Elsevier
- Vol. 145, 55-93
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
- 1 January 2020
- Published by Elsevier
- Vol. 145, 55-93
The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases
- 10 December 2019
- Published by Springer Nature in Nature Immunology
- Vol. 21 (1) , 9-11
ApoC3: an ‘alarmin’ triggering sterile inflammation
- 10 December 2019
- Published by Springer Nature in Nature Immunology
- Vol. 21 (1) , 9-11
ApoC3: an ‘alarmin’ triggering sterile inflammation
- 21 October 2019
- Published by Springer Nature in Nature Immunology
- Vol. 20 (12) , 1681-1691
Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling
Much attention has focused on commensal bacteria in health and disease, but the role of commensal viruses is understudied. Although metagenomic analysis shows that the intestine of healthy humans and animals harbors various commensal viruses and the dysbiosis of these viruses can be associated with inflammatory diseases, there is still a lack of causal data and underlying mechanisms to understand the physiological role of commensal viruses in intestinal homeostasis. In the present study, we show that commensal viruses are essential for the homeostasis of intestinal intraepithelial lymphocytes (IELs). Mechanistically, the cytosolic viral RNA-sensing receptor RIG-I in antigen-presenting cells can recognize commensal viruses and maintain IELs via a type I interferon–independent, but MAVS-IRF1-IL-15 axis-dependent, manner. The recovery of IELs by interleukin-15 administration reverses the susceptibility of commensal virus-depleted mice to dextran sulfate sodium–induced colitis. Collectively, our results indicate that commensal viruses maintain the IELs and consequently sustain intestinal homeostasis via noncanonical RIG-I signaling.
- 21 October 2019
- Published by Springer Nature in Nature Immunology
- Vol. 20 (12) , 1681-1691
Commensal viruses maintain intestinal intraepithelial lymphocytes via noncanonical RIG-I signaling
Much attention has focused on commensal bacteria in health and disease, but the role of commensal viruses is understudied. Although metagenomic analysis shows that the intestine of healthy humans and animals harbors various commensal viruses and the dysbiosis of these viruses can be associated with inflammatory diseases, there is still a lack of causal data and underlying mechanisms to understand the physiological role of commensal viruses in intestinal homeostasis. In the present study, we show that commensal viruses are essential for the homeostasis of intestinal intraepithelial lymphocytes (IELs). Mechanistically, the cytosolic viral RNA-sensing receptor RIG-I in antigen-presenting cells can recognize commensal viruses and maintain IELs via a type I interferon–independent, but MAVS-IRF1-IL-15 axis-dependent, manner. The recovery of IELs by interleukin-15 administration reverses the susceptibility of commensal virus-depleted mice to dextran sulfate sodium–induced colitis. Collectively, our results indicate that commensal viruses maintain the IELs and consequently sustain intestinal homeostasis via noncanonical RIG-I signaling.
- Top Cited Papers
- 26 September 2019
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 20 (2) , 95-112
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
The innate immune system has the capacity to detect ‘non-self’ molecules derived from pathogens, known as pathogen-associated molecular patterns, via pattern recognition receptors. In addition, an increasing number of endogenous host-derived molecules, termed damage-associated molecular patterns (DAMPs), have been found to be sensed by various innate immune receptors. The recognition of DAMPs, which are produced or released by damaged and dying cells, promotes sterile inflammation, which is important for tissue repair and regeneration, but can also lead to the development of numerous inflammatory diseases, such as metabolic disorders, neurodegenerative diseases, autoimmune diseases and cancer. Here we examine recent discoveries concerning the roles of DAMP-sensing receptors in sterile inflammation and in diseases resulting from dysregulated sterile inflammation, and then discuss insights into the cross-regulation of these receptors and their ligands.
- 26 September 2019
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 20 (2) , 95-112
Top Cited PapersDAMP-sensing receptors in sterile inflammation and inflammatory diseases
The innate immune system has the capacity to detect ‘non-self’ molecules derived from pathogens, known as pathogen-associated molecular patterns, via pattern recognition receptors. In addition, an increasing number of endogenous host-derived molecules, termed damage-associated molecular patterns (DAMPs), have been found to be sensed by various innate immune receptors. The recognition of DAMPs, which are produced or released by damaged and dying cells, promotes sterile inflammation, which is important for tissue repair and regeneration, but can also lead to the development of numerous inflammatory diseases, such as metabolic disorders, neurodegenerative diseases, autoimmune diseases and cancer. Here we examine recent discoveries concerning the roles of DAMP-sensing receptors in sterile inflammation and in diseases resulting from dysregulated sterile inflammation, and then discuss insights into the cross-regulation of these receptors and their ligands.
- 5 September 2018
- Published by Wiley in European Journal of Immunology
- Vol. 48 (11) , 1817-1825
NLRP2 negatively regulates antiviral immunity by interacting with TBK1
Nucleotide‐binding oligomerization domain (NOD)‐like receptors (NLRs) are intracellular pattern recognition receptors (PRRs) that regulate a variety of inflammatory and host defense responses. Unlike the well‐established NLRs, the roles of NLRP2 are controversial and poorly defined. Here, we report that NLRP2 acts as a negative regulator of TANK‐binding kinase 1 (TBK1)‐mediated type I interferon (IFN) signaling. Mechanistically, NLRP2 interacted directly with TBK1, and this binding disrupted the interaction of TBK1 and interferon regulatory factor 3 (IRF3), which interfered with TBK1‐induced IRF3 phosphorylation. IFNs induce a series of proteins that have well‐known antiviral or immune‐regulatory functions, and tight control of the IFN signaling cascade is critical for limiting tissue damage and preventing autoimmunity. Our studies indicate that the NLRP2‐TBK1 axis may serve as an additional signaling cascade to maintain immune homeostasis in response to viral infection.
- 5 September 2018
- Published by Wiley in European Journal of Immunology
- Vol. 48 (11) , 1817-1825
NLRP2 negatively regulates antiviral immunity by interacting with TBK1
Nucleotide‐binding oligomerization domain (NOD)‐like receptors (NLRs) are intracellular pattern recognition receptors (PRRs) that regulate a variety of inflammatory and host defense responses. Unlike the well‐established NLRs, the roles of NLRP2 are controversial and poorly defined. Here, we report that NLRP2 acts as a negative regulator of TANK‐binding kinase 1 (TBK1)‐mediated type I interferon (IFN) signaling. Mechanistically, NLRP2 interacted directly with TBK1, and this binding disrupted the interaction of TBK1 and interferon regulatory factor 3 (IRF3), which interfered with TBK1‐induced IRF3 phosphorylation. IFNs induce a series of proteins that have well‐known antiviral or immune‐regulatory functions, and tight control of the IFN signaling cascade is critical for limiting tissue damage and preventing autoimmunity. Our studies indicate that the NLRP2‐TBK1 axis may serve as an additional signaling cascade to maintain immune homeostasis in response to viral infection.
- 1 September 2018
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 43 (9) , 685-699
Control of Inflammasome Activation by Phosphorylation
- 1 September 2018
- Published by Elsevier in Trends in Biochemical Sciences
- Vol. 43 (9) , 685-699
Control of Inflammasome Activation by Phosphorylation